ABOS's logo.
Ticker Symbol: ABOS

Acumen Pharmaceuticals Inc

$10.73 - 04-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001576885

Company Profile

acumen is forging a new path towards safe and effective treatments for alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers. our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (aβo) in synaptic dysfunction and neurodegeneration. these early insights have fostered decades of research on the biology of aβo at acumen and throughout the field. we are now on the on cusp of realizing the therapeutic potential of aβo targeted drugs.

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
CEO: N/A
Tags: N/A

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $3.46
Change: -$0.03 ( -0.86%)
Days Range: $3.39 - $3.62
Beta: 1.11
52wk. High: $11.31
52wk. Low: $3.41
Ytd. Change -36.79%
50 Day Moving Average: $4.67
200 Day Moving Average: $5.35
Shares Outstanding: 57868512

Valuation

Market Cap: 20.0B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A